<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//www.enorama.se/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://www.enorama.se/cision/</loc>
		<lastmod>2026-08-28T10:25:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-erhaller-111-msek-via-nyemission-tecknar-lan-om-5-msek/</loc>
		<lastmod>2026-08-28T10:25:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/delarsrapport-enorama-pharma-ab-17/</loc>
		<lastmod>2026-08-28T10:25:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-genomfor-nyemission-om-23-msek-infor-notering-pa-nasdaq-first-north/</loc>
		<lastmod>2026-08-28T10:25:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-genomfor-nyemission-om-23-msek-infor-notering-pa-nasdaq-first-north-2/</loc>
		<lastmod>2026-08-28T10:25:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/arsredovisning-och-revisionsberattelse-och-kommentar-till-revisorns-uttalande-i-revisionsberattelse-2/</loc>
		<lastmod>2026-08-28T10:25:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/kallelse-till-arsstamma-i-enorama-pharma-ab-publ-12/</loc>
		<lastmod>2026-08-28T10:25:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/forandringar-i-styrelsen/</loc>
		<lastmod>2026-08-28T10:25:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/bokslutsrapport-enorama-pharma-ab-2/</loc>
		<lastmod>2026-08-28T10:25:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/positivt-resultat-i-enorama-pharmas-pilotstudie/</loc>
		<lastmod>2026-08-28T10:25:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/delarsrapport-enorama-pharma-ab-15/</loc>
		<lastmod>2026-08-28T10:25:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/positivt-utfall-for-enorama-pharma-i-sensorisk-analys/</loc>
		<lastmod>2026-08-28T10:25:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-har-inlett-sensorisk-analys-av-medicinska-tuggummin/</loc>
		<lastmod>2026-08-28T10:25:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-inleder-utveckling-av-medicinska-tuggummin-mot-allergiska-besvar/</loc>
		<lastmod>2026-08-28T10:25:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/delarsrapport-enorama-pharma-ab-16/</loc>
		<lastmod>2026-08-28T10:25:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-godkanns-for-listning-pa-nasdaq-first-north/</loc>
		<lastmod>2026-08-28T10:25:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-har-sakrat-bryggfinansiering-om-70-msek/</loc>
		<lastmod>2026-08-28T10:25:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/kommunike-fran-arsstamman-i-enorama-pharma-ab-publ-8/</loc>
		<lastmod>2026-08-28T10:25:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/delarsrapport-enorama-pharma-ab-14/</loc>
		<lastmod>2026-08-28T10:25:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/anders-jungbeck-foreslas-som-ny-styrelseledamot-i-enorama-pharma-ab/</loc>
		<lastmod>2026-08-28T10:25:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-ingar-laneavtal-med-bolagets-huvudagare-swede-unipharma-ab-och-lanar-75-msek-av-swede-unipharma-ab/</loc>
		<lastmod>2026-08-28T10:25:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-mars-april-2017/</loc>
		<lastmod>2026-08-28T10:25:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-visar-upp-positivt-resultat-i-bioekvivalensstudie/</loc>
		<lastmod>2026-08-28T10:25:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-har-startat-utvecklingsarbetet-for-den-nordamerikanska-marknaden-och-erhallit-sin-forsta-intakt-fran-dr-reddys-laboratories-ltd/</loc>
		<lastmod>2026-08-28T10:25:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-kvittar-brygglan-mot-aktier/</loc>
		<lastmod>2026-08-28T10:25:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-har-sakrat-bryggfinansiering-om-10-msek/</loc>
		<lastmod>2026-08-28T10:25:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/delarsrapport-enorama-pharma-ab-12/</loc>
		<lastmod>2026-08-28T10:25:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-lagger-om-bryggfinansiering/</loc>
		<lastmod>2026-08-28T10:25:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-har-ingatt-ett-samarbetsavtal-med-dr-reddys-laboratories-ltd-om-utveckling-och-forsaljning-av-nikotintuggummi-i-nordamerika/</loc>
		<lastmod>2026-08-28T10:25:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/information-gallande-handelsstopp-och-pagaende-avtalsforhandlingar/</loc>
		<lastmod>2026-08-28T10:25:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/delarsrapport-enorama-pharma-ab-13/</loc>
		<lastmod>2026-08-28T10:25:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-maj-juni-2017/</loc>
		<lastmod>2026-08-28T10:25:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-ansoker-om-formuleringspatent/</loc>
		<lastmod>2026-08-28T10:25:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-visar-upp-positivt-resultat-i-stabilitetsstudie/</loc>
		<lastmod>2026-08-28T10:25:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/huvudagaren-i-enorama-pharma-starker-bolagets-egna-kapital-med-4-msek/</loc>
		<lastmod>2026-08-28T10:25:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/bokslutsrapport-enorama-pharma-ab/</loc>
		<lastmod>2026-08-28T10:25:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-har-ansokt-om-partihandelstillstand-hos-lakemedelsverket/</loc>
		<lastmod>2026-08-28T10:25:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-byter-certified-adviser-till-erik-penser-bank-ab/</loc>
		<lastmod>2026-08-28T10:25:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/harlig-sommar-onskar-enorama-pharma/</loc>
		<lastmod>2026-08-28T10:25:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-gor-om-bioekvivalensstudie/</loc>
		<lastmod>2026-08-28T10:25:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-har-beslutat-om-att-starta-utvecklingsarbetet-av-medicinskt-cannabistuggummi/</loc>
		<lastmod>2026-08-28T10:25:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-ingar-laneavtal-med-swede-unipharma-ab/</loc>
		<lastmod>2026-08-28T10:25:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-anlitar-erik-penser-bank-som-likviditetsgarant-i-bolagets-aktie/</loc>
		<lastmod>2026-08-28T10:25:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/kommunike-fran-arsstamman-i-enorama-pharma-ab-publ-7/</loc>
		<lastmod>2026-08-28T10:25:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/delarsrapport-enorama-pharma-ab-11/</loc>
		<lastmod>2026-08-28T10:25:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-utvidgar-styrelsen/</loc>
		<lastmod>2026-08-28T10:25:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/arsredovisning-och-revisionsberattelse-och-kommentar-till-revisorns-uttalande-i-revisionsberattelse/</loc>
		<lastmod>2026-08-28T10:25:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/kallelse-till-arsstamma-i-enorama-pharma-ab-publ-11/</loc>
		<lastmod>2026-08-28T10:25:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-ingar-laneavtal-med-bolagets-huvudagare-swede-unipharma-ab/</loc>
		<lastmod>2026-08-28T10:25:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/fortydligande-med-anledning-av-intervju-med-enorama-pharmas-vvd-annette-agerskov-i-biostocks-sondagsintervju-2018-04-08/</loc>
		<lastmod>2026-08-28T10:25:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-i-mal-med-samtliga-tester-av-nikotintuggummit/</loc>
		<lastmod>2026-08-28T10:25:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-visar-upp-nytt-positivt-resultat-i-stabilitetsstudie/</loc>
		<lastmod>2026-08-28T10:25:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-publ-har-idag-skrivit-avtal-med-mae-holding-om-forsaljning-av-nikotintuggummi-i-holland/</loc>
		<lastmod>2026-08-28T10:25:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-etablerar-laboratorium-for-medicinsk-cannabis/</loc>
		<lastmod>2026-08-28T10:25:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/delarsrapport-enorama-pharma-ab-10/</loc>
		<lastmod>2026-08-28T10:25:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-har-slutfort-screeningstudie-inom-cough-cold-segmentet/</loc>
		<lastmod>2026-08-28T10:25:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/tillsattande-av-valberedning/</loc>
		<lastmod>2026-08-28T10:25:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-inrattar-ett-ersattningsutskott/</loc>
		<lastmod>2026-08-28T10:25:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-ingar-avtal-med-mediigum-llc-rorande-forstudier-inom-cough-cold-segmentet/</loc>
		<lastmod>2026-08-28T10:25:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/kommunike-fran-arsstamman-i-enorama-pharma-ab-publ-6/</loc>
		<lastmod>2026-08-28T10:25:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-har-mottagit-forsta-omgangen-fragor-pa-sin-registreringsansokan-hos-lakemedelsverket/</loc>
		<lastmod>2026-08-28T10:25:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-har-idag-mottagit-andra-omgangen-fragor-pa-sin-registreringsansokan-hos-lakemedelsverket/</loc>
		<lastmod>2026-08-28T10:25:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/sista-dag-for-handel-med-bta/</loc>
		<lastmod>2026-08-28T10:25:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/delarsrapport-enorama-pharma-3/</loc>
		<lastmod>2026-08-28T10:25:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharmas-foretradesemission-overtecknades-tecknad-till-152-procent/</loc>
		<lastmod>2026-08-28T10:25:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharmas-ansokan-om-formuleringspatent-for-nikotintuggummit-forvantas-beviljas-i-juni/</loc>
		<lastmod>2026-08-28T10:25:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/delarsrapport-enorama-pharma-4/</loc>
		<lastmod>2026-08-28T10:25:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-beslutar-etablera-en-sjalvstandig-enhet-inom-tobaksfria-nikotinprodukter-ej-lakemedel-och-soker-samarbetspartners/</loc>
		<lastmod>2026-08-28T10:25:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-offentliggorande-av-informationsmemorandum/</loc>
		<lastmod>2026-08-28T10:25:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/kallelse-till-arsstamma-i-enorama-pharma-ab-publ-10/</loc>
		<lastmod>2026-08-28T10:25:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/rattelse-enorama-pharma-erhaller-tillstand-att-hantera-cannabis/</loc>
		<lastmod>2026-08-28T10:25:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/arsredovisning-revisionsberattelse-och-kommentar-till-forvaltningsberattelsen/</loc>
		<lastmod>2026-08-28T10:25:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-erhaller-tillstand-att-hantera-cannabis/</loc>
		<lastmod>2026-08-28T10:25:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/forandring-i-valberedningen/</loc>
		<lastmod>2026-08-28T10:25:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-beslutar-om-foretradesemission-om-25-msek-fokus-pa-lansering-av-nikotintuggummi/</loc>
		<lastmod>2026-08-28T10:25:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-har-skickat-in-begarda-kompletteringar-pa-sin-registreringsansokan-till-lakemedelsverket-2/</loc>
		<lastmod>2026-08-28T10:25:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-tidigarelagger-delarsrapport-for-tredje-kvartalet/</loc>
		<lastmod>2026-08-28T10:25:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-etablerar-intern-ekonomifunktion-och-soker-chief-financial-officer-till-kontoret-i-malmo/</loc>
		<lastmod>2026-08-28T10:25:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-har-passerat-lakemedelsverkets-valideringsfas-for-registreringsansokningar/</loc>
		<lastmod>2026-08-28T10:25:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-har-mottagit-den-tertiara-utredningen-pa-sin-registreringsansokan-hos-lakemedelsverket/</loc>
		<lastmod>2026-08-28T10:25:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/valberedning/</loc>
		<lastmod>2026-08-28T10:25:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/martin-lind-lamnar-styrelsen-i-enorama-pharma-ab/</loc>
		<lastmod>2026-08-28T10:25:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharmas-vag-mot-ett-tuggummi-med-medicinsk-cannabis/</loc>
		<lastmod>2026-08-28T10:25:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-kommer-att-svara-pa-lakemedelsverkets-kompletteringsfragor-drygt-fyra-veckor-fore-utsatt-tid/</loc>
		<lastmod>2026-08-28T10:25:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-sander-in-registreringsansokningar-till-svenska-lakemedelsverket/</loc>
		<lastmod>2026-08-28T10:25:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-har-skickat-in-begarda-kompletteringar-pa-sin-registreringsansokan-till-lakemedelsverket/</loc>
		<lastmod>2026-08-28T10:25:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/bokslutskommunike-enorama-pharma-ab-5/</loc>
		<lastmod>2026-08-28T10:25:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-erhaller-partihandelstillstand/</loc>
		<lastmod>2026-08-28T10:25:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-mottar-order-pa-tobaksfria-nikotinpasar/</loc>
		<lastmod>2026-08-28T10:25:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/delarsrapport-enorama-pharma-ab-9/</loc>
		<lastmod>2026-08-28T10:25:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-ansoker-om-patent-rorande-fyllningsprocess-for-nikotinpulver-med-upptag-i-munhalan/</loc>
		<lastmod>2026-08-28T10:25:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-publ-har-ingatt-term-sheet-avtal-med-betapharm-arzneimittel-gmbh-om-forsaljning-av-nikotintuggummi-i-tyskland/</loc>
		<lastmod>2026-08-28T10:25:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-ansoker-om-patent-for-nikotinpulver-med-upptag-i-munhalan/</loc>
		<lastmod>2026-08-28T10:25:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-har-meddelat-lakemedelsverket-vilka-lander-som-ska-inga-i-bolagets-forsta-mrp-ansokan/</loc>
		<lastmod>2026-08-28T10:25:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-har-fatt-besked-att-lakemedelsverket-accepterar-begaran-om-att-sverige-ska-agera-referensland-i-kommande-mrp/</loc>
		<lastmod>2026-08-28T10:25:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-har-skickat-in-begaran-till-svenska-lakemedelsverket-om-att-sverige-ska-agera-referensland-i-kommande-mrp/</loc>
		<lastmod>2026-08-28T10:25:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-erhaller-patentgodkannande-fran-patent-och-registreringsverket-for-nikotintuggummits-formulering/</loc>
		<lastmod>2026-08-28T10:25:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/delarsrapport-enorama-pharma-2/</loc>
		<lastmod>2026-08-28T10:25:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-genomfor-riktad-nyemission-om-150-msek/</loc>
		<lastmod>2026-08-28T10:25:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-har-ingatt-tillaggsavtal-med-evolan-pharma-ab-om-forsaljning-av-nikotintuggummi-pa-atta-nordeuropeiska-marknader/</loc>
		<lastmod>2026-08-28T10:25:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-erhaller-godkannande-for-nikotintuggummit-fran-lakemedelsverket/</loc>
		<lastmod>2026-08-28T10:25:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/bokslutskommunike-enorama-pharma-ab-4/</loc>
		<lastmod>2026-08-28T10:25:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-har-skickat-in-foreslagna-kompletteringar-pa-sin-registreringsansokan-till-lakemedelsverket/</loc>
		<lastmod>2026-08-28T10:25:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/rattelse-enorama-pharma-sakrar-finansiering-genom-laneavtal-om-17-msek-och-refinansierar-befintligt-lan-om-18-msek-med-swede-unipharma-ab/</loc>
		<lastmod>2026-08-28T10:25:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-sakrar-finansiering-genom-laneavtal-om-17-msek-och-refinansierar-befintligt-lan-om-18-msek-med-swede-unipharma-ab/</loc>
		<lastmod>2026-08-28T10:25:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-mottar-sin-andra-amerikanska-order-pa-tobaksfria-nikotinpasar/</loc>
		<lastmod>2026-08-28T10:25:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-publ-har-ingatt-term-sheet-avtal-med-igrp-lda-ig-therapeutics-om-forsaljning-av-nikotintuggummi-i-bl-a-portugal/</loc>
		<lastmod>2026-08-28T10:25:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-har-mottagit-en-invandning-pa-det-svenska-patentet-for-nikotintuggummits-formulering/</loc>
		<lastmod>2026-08-28T10:25:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-ingar-avtal-med-twinroll-service-ab-om-internationell-forsaljning-av-tobaksfritt-vitt-snus/</loc>
		<lastmod>2026-08-28T10:25:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-ingar-avtal-med-northerner-om-forsaljning-av-tobaksfritt-vitt-snus-till-konsumenter-i-usa/</loc>
		<lastmod>2026-08-28T10:25:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/kallelse-till-arsstamma-i-enorama-pharma-ab-publ-8/</loc>
		<lastmod>2026-08-28T10:25:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/utfall-teckningsoptioner-utgivna-2020-10-26/</loc>
		<lastmod>2026-08-28T10:25:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/delarsrapport-enorama-pharma/</loc>
		<lastmod>2026-08-28T10:25:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/nationellt-godkannande-i-samtliga-sju-lander-i-mrp-ansokan/</loc>
		<lastmod>2026-08-28T10:25:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-skjuter-upp-arsstamman-till-den-26-juni-2020-for-att-kunna-genomfora-arsstamman-digitalt-utan-personlig-narvaro/</loc>
		<lastmod>2026-08-28T10:25:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/godkand-registreringsansokan-av-nikotintuggummi-i-sverige/</loc>
		<lastmod>2026-08-28T10:25:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-ingar-licens-och-leveransavtal-med-betapharm-arzneimittel-gmbh-om-forsaljning-av-nikotintuggummi-i-tyskland/</loc>
		<lastmod>2026-08-28T10:25:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-genomfor-riktad-nyemission-av-aktier-och-tillfors-72-miljoner-kronor/</loc>
		<lastmod>2026-08-28T10:25:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/mrp-processen-for-enorama-pharmas-nikotintuggummi-ar-avslutad-och-samtliga-lander-dar-ansokan-skickats-in-ar-overens-om-att-produkten-uppfyller-alla-krav-for-godkannande/</loc>
		<lastmod>2026-08-28T10:25:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/bokslutskommunike-enorama-pharma-ab-3/</loc>
		<lastmod>2026-08-28T10:25:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharmas-bolagsstamma-flyttas-till-annan-lokal/</loc>
		<lastmod>2026-08-28T10:25:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-ingar-laneavtal-om-8-msek-med-ds-global-pte-limited/</loc>
		<lastmod>2026-08-28T10:25:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/kallelse-till-arsstamma-i-enorama-pharma-ab-publ-9/</loc>
		<lastmod>2026-08-28T10:25:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/delarsrapport-enorama-pharma-ab-7/</loc>
		<lastmod>2026-08-28T10:25:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/arsredovisning-och-revisionsberattelse-4/</loc>
		<lastmod>2026-08-28T10:25:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-genomfor-riktad-nyemission-av-units-och-tillfors-initialt-ca-13-miljoner-kronor-och-potentiellt-ytterligare-75-miljoner-kronor-vid-fullt-nyttjande-av-teckningsoptioner/</loc>
		<lastmod>2026-08-28T10:25:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-ingar-laneavtal-om-5-msek-med-nordea-bank-abp/</loc>
		<lastmod>2026-08-28T10:25:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/delarsrapport-enorama-pharma-ab-8/</loc>
		<lastmod>2026-08-28T10:25:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/huvudagaren-i-enorama-pharma-starker-bolagets-egna-kapital-med-5-msek/</loc>
		<lastmod>2026-08-28T10:25:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/kommunike-fran-arsstamman-i-enorama-pharma-ab-publ-5/</loc>
		<lastmod>2026-08-28T10:25:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/kommunike-fran-extra-bolagsstamma-den-23-december-2022-i-enorama-pharma-ab-publ/</loc>
		<lastmod>2026-08-28T10:25:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-ingar-nytt-avtal-med-twinroll-service-ab-om-internationell-forsaljning-av-tobaksfritt-vitt-snus/</loc>
		<lastmod>2026-08-28T10:25:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-skjuter-upp-arsstamman-till-den-23-juni-2021/</loc>
		<lastmod>2026-08-28T10:25:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/kallelse-till-extra-bolagsstamma-i-enorama-pharma-ab-publ-3/</loc>
		<lastmod>2026-08-28T10:25:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/avtalet-mellan-enorama-pharma-publ-och-evolan-pharma-ab-upphor/</loc>
		<lastmod>2026-08-28T10:25:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/kallelse-till-arsstamma-i-enorama-pharma-ab-publ-7/</loc>
		<lastmod>2026-08-28T10:25:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-genomfor-riktad-nyemission-och-planerar-en-extra-bolagsstamma-for-beslut-om-ytterligare-riktade-nyemissioner-beslut-om-andring-av-bolagsordning-samt-forlangning-av-laneavtal-med-narstaende/</loc>
		<lastmod>2026-08-28T10:25:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/delarsrapport-enorama-pharma-ab-4/</loc>
		<lastmod>2026-08-28T10:25:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/arsredovisning-och-revisionsberattelse-3/</loc>
		<lastmod>2026-08-28T10:25:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/delarsrapport-enorama-pharma-ab/</loc>
		<lastmod>2026-08-28T10:25:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/kommunike-fran-extrastamma-i-enorama-pharma-ab-publ/</loc>
		<lastmod>2026-08-28T10:25:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/jonas-sohlman-fortsatter-bitrada-enorama-pa-konsultbasis/</loc>
		<lastmod>2026-08-28T10:25:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/kallelse-till-extra-bolagsstamma-i-enorama-pharma-ab-publ-4/</loc>
		<lastmod>2026-08-28T10:25:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/delarsrapport-enorama-pharma-ab-2/</loc>
		<lastmod>2026-08-28T10:25:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-genomfor-riktad-nyemission-av-1-191-490-aktier-till-dharampal-satyapal-limited-och-tillfors-genom-emissionen-ca-28-msek/</loc>
		<lastmod>2026-08-28T10:25:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-valjer-viskan-som-e-handelsplattform-och-systemleverantor/</loc>
		<lastmod>2026-08-28T10:25:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-publ-avser-att-genomfora-en-riktad-nyemission-av-1-191-490-aktier-till-dharampal-satyapal-limited-och-tillfors-genom-emissionen-ca-28-msek/</loc>
		<lastmod>2026-08-28T10:25:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/kommunike-fran-arsstamman-i-enorama-pharma-ab-publ-3/</loc>
		<lastmod>2026-08-28T10:25:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-publ-har-ingatt-term-sheet-avtal-med-maple-healthcare-pty-ltd-maple-om-forsaljning-av-nikotintuggummi-i-australien-och-nya-zeeland/</loc>
		<lastmod>2026-08-28T10:25:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/delarsrapport-enorama-pharma-ab-3/</loc>
		<lastmod>2026-08-28T10:25:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-erhaller-godkannande-for-patent-avseende-fyllningsprocess-for-produktion-av-nikotinpasar/</loc>
		<lastmod>2026-08-28T10:25:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-ingar-laneavtal-om-20-msek-med-ds-global-pte-limited/</loc>
		<lastmod>2026-08-28T10:25:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/fortydligande-angaende-enorama-pharmas-genomforda-riktade-nyemission-av-320-000-aktier-genom-vilket-bolaget-tillforts-8-miljoner-kronor/</loc>
		<lastmod>2026-08-28T10:25:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/kallelse-till-arsstamma-i-enorama-pharma-ab-publ-5/</loc>
		<lastmod>2026-08-28T10:25:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-genomfor-riktad-nyemission-av-320-000-aktier-och-tillfors-8-miljoner-kronor/</loc>
		<lastmod>2026-08-28T10:25:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/arsredovisning-och-revisionsberattelse-2/</loc>
		<lastmod>2026-08-28T10:25:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/delarsrapport-enorama-pharma-ab-5/</loc>
		<lastmod>2026-08-28T10:25:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/kallelse-till-arsstamma-i-enorama-pharma-ab-publ-4/</loc>
		<lastmod>2026-08-28T10:25:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/jonas-sohlman-slutar-som-cfo-for-enorama-pharma/</loc>
		<lastmod>2026-08-28T10:25:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/huvudagaren-i-enorama-pharma-starker-bolagets-egna-kapital-med-6-msek/</loc>
		<lastmod>2026-08-28T10:25:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-ab-senarelagger-publicering-av-arsredovisning-for-rakenskapsaret-2022/</loc>
		<lastmod>2026-08-28T10:25:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/bokslutskommunike-enorama-pharma-ab-2/</loc>
		<lastmod>2026-08-28T10:25:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/kommunike-fran-arsstamman-i-enorama-pharma-ab-publ-4/</loc>
		<lastmod>2026-08-28T10:25:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-ab-senarelagger-arsstamma/</loc>
		<lastmod>2026-08-28T10:25:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/annette-agerskov-slutar-som-vice-vd-for-enorama-pharma/</loc>
		<lastmod>2026-08-28T10:25:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/kallelse-till-arsstamma-i-enorama-pharma-ab-publ-6/</loc>
		<lastmod>2026-08-28T10:25:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/bokslutskommunike-enorama-pharma-ab/</loc>
		<lastmod>2026-08-28T10:25:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharmas-nikotintuggummi-lanserat-i-tyskland/</loc>
		<lastmod>2026-08-28T10:25:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/delarsrapport-enorama-pharma-ab-6/</loc>
		<lastmod>2026-08-28T10:25:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/styrelsen-i-enorama-pharma-ab-publ-beslutar-om-andring-av-villkor-i-tidigare-beslutad-foretradesemission-om-cirka-2865-msek/</loc>
		<lastmod>2026-08-28T10:25:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-ab-planerar-att-genomfora-en-riktad-emission-om-hogst-315-msek/</loc>
		<lastmod>2026-08-28T10:25:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-ab-beslutar-att-genomfora-en-riktad-emission-om-ca-118-msek-till-en-strategiskt-viktig-investerare/</loc>
		<lastmod>2026-08-28T10:25:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-ab-har-idag-beslutat-att-genomfora-en-riktad-emission-om-ca-20-msek-till-strategiskt-viktig-investerare-enligt-tidigare-pressmeddelande/</loc>
		<lastmod>2026-08-28T10:25:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/styrelsen-i-enorama-pharma-ab-beslutar-om-foretradesemission-av-aktier-om-cirka-2865-msek/</loc>
		<lastmod>2026-08-28T10:25:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-ab-planerar-att-genomfora-en-riktad-emission-om-ca-20-msek-till-strategiskt-viktig-investerare/</loc>
		<lastmod>2026-08-28T10:25:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/bokslutskommunike-enorama-pharma-ab-publ-2/</loc>
		<lastmod>2026-08-28T10:25:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/annette-agerskov-tilltrader-som-interim-vd-for-enorama-pharma-ab/</loc>
		<lastmod>2026-08-28T10:25:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/kallelse-till-extra-bolagsstamma-i-enorama-pharma-ab-publ/</loc>
		<lastmod>2026-08-28T10:25:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-ab-genomfor-forandring-i-ledningsgruppen-vd-entledigas/</loc>
		<lastmod>2026-08-28T10:25:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-ab-publ-erhaller-besked-fran-europeiska-patentverket-om-avsikt-att-godkanna-nytt-patent/</loc>
		<lastmod>2026-08-28T10:25:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/kommunike-fran-arsstamman-i-enorama-pharma-ab-publ-2/</loc>
		<lastmod>2026-08-28T10:25:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharmas-dotterbolag-enorama-pharma-inc-ingar-distributionsavtal-med-madhat-ab-villkorat-av-efterfoljande-godkannande-av-bolagsstamma/</loc>
		<lastmod>2026-08-28T10:25:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/arsredovisning-och-revisionsberattelse/</loc>
		<lastmod>2026-08-28T10:25:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-ab-publ-senarelagger-publicering-av-arsredovisning-for-rakenskapsaret-2023/</loc>
		<lastmod>2026-08-28T10:25:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/kallelse-till-extra-bolagsstamma-i-enorama-pharma-ab-publ-2/</loc>
		<lastmod>2026-08-28T10:25:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/kvartalsrapport-enorama-pharma-ab-2/</loc>
		<lastmod>2026-08-28T10:25:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-ab-publ-senarelagger-arsstamma-till-den-5-juni-2024/</loc>
		<lastmod>2026-08-28T10:25:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/hemstallan-om-extra-bolagsstamma-i-enorama-pharma-ab-publ/</loc>
		<lastmod>2026-08-28T10:25:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/kallelse-till-arsstamma-i-enorama-pharma-ab-publ-3/</loc>
		<lastmod>2026-08-28T10:25:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-ab-publ-meddelar-sista-dag-for-handel-med-bta/</loc>
		<lastmod>2026-08-28T10:25:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/andring-i-enorama-pharma-ab-publs-valberedning/</loc>
		<lastmod>2026-08-28T10:25:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/kvartalsrapport-enorama-pharma-ab-3/</loc>
		<lastmod>2026-08-28T10:25:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-ab-publ-offentliggor-utfall-i-foretradesemission-2/</loc>
		<lastmod>2026-08-28T10:25:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-ab-publ-byter-likviditetsgarant-och-certified-adviser-till-carnegie-investment-bank-ab-publ/</loc>
		<lastmod>2026-08-28T10:25:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/styrelseledamot-avgar-pa-egen-begaran/</loc>
		<lastmod>2026-08-28T10:25:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/styrelsen-i-enorama-pharma-ab-beslutar-om-forlangning-av-teckningstid-i-pagaende-foretradesemission-till-2-april-2024/</loc>
		<lastmod>2026-08-28T10:25:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-ab-publ-har-mottagit-stamningsansokan-fran-roccia-ab/</loc>
		<lastmod>2026-08-28T10:25:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-ab-senarelagger-publicering-av-arsredovisning-for-rakenskapsaret-2022-och-delarsrapport-for-perioden-1-januari-31-mars-2023-samt-senarelagger-arsstamman/</loc>
		<lastmod>2026-08-28T10:25:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-ab-publ-offentliggor-informationsmemorandum-med-anledning-av-foretradesemission-av-aktier-om-cirka-2865-msek/</loc>
		<lastmod>2026-08-28T10:25:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/kvartalsrapport-enorama-pharma-ab-publ-6/</loc>
		<lastmod>2026-08-28T10:25:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/cision/enorama-pharma-ab-publ-ingar-forlikningsavtal-med-roccia-ab/</loc>
		<lastmod>2026-08-28T10:25:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.enorama.se/en/cision/</loc>
		<lastmod>2026-08-28T10:25:13+00:00</lastmod>
	</url>
</urlset>
<!-- XML Sitemap generated by Rank Math SEO Plugin (c) Rank Math - rankmath.com -->